National estimates of medical costs incurred by nonelderly cancer patients

@article{Howard2004NationalEO,
  title={National estimates of medical costs incurred by nonelderly cancer patients},
  author={David H Howard and Noelle-Angelique M. Molinari and Kenneth E. Thorpe},
  journal={Cancer},
  year={2004},
  volume={100}
}
Estimates of the cost of treating common illnesses are important for allocating prevention and research funds optimally, for understanding the impact of each disease on federal and state budgets, and for quantifying the costs of disease-specific insurance expansions and programs. Existing estimates of the cost of cancer care in the U.S. rely on several different approaches. Although total spending estimates are similar, each approach entails strong assumptions and may produce inaccurate… 

Medical Care Costs Associated With Cancer in Integrated Delivery Systems.

TLDR
Higher costs among patients aged <65 years highlight limitations of relying on SEER-Medicare data alone to understand the national burden of cancer, whereas higher costs for patients with advanced-stage cancer underscore the importance of early detection to curtail high long-term costs.

State-level projections of cancer-related medical care costs: 2010 to 2020.

TLDR
The number of people treated for cancer and the costs of their cancer-related medical care are projected to increase substantially for each state from 2010 through 2020, and effective prevention and early detection strategies are needed.

Comparison of Approaches for Estimating Incidence Costs of Care for Colorectal Cancer Patients

TLDR
CRC incidence cost estimates vary substantially depending on the strategy and data source for identifying newly diagnosed cancer patients and methods for estimating longitudinal costs, which may inform estimation of costs for other cancers as well as other diseases.

Comparison of Approaches for Estimating Prevalence Costs of Care for Cancer Patients: What Is the Impact of Data Source?

TLDR
This study compared 3 approaches for estimating the prevalence costs of colorectal cancer care using different data sources, but similar patient populations and methods to find considerable variability across the different approaches.

Medicaid Expenditures for Cancer: Evidence from Medicaid-only Beneficiaries in Four States

TLDR
This study estimates the cost burden of 6 prevalent invasive cancers—breast, cervical, colorectal, lung, melanoma, and prostate—on Medicaid programs in 4 states from 2000 to 2003 and adjusts for sociodemographics and comorbidities.

National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008.

TLDR
Although a detailed patient-physician discussion of costs of care may not be feasible, it is believed that an awareness of out-of-pocket burdens among patients with cancer is useful for clinical oncologists.

Annual Patient Time Costs Associated With Medical Care Among Cancer Survivors in the United States

TLDR
Cancer survivors had greater annual medical service use and patient time costs than individuals without a cancer history and this medical service-based approach for estimating annual time costs can also be applied to other conditions.

Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data.

Costs of asthma in the United States: 2002-2007.

Recent Health Care Expenditure Trends Among Adult Cancer Survivors in United States, 2009-2016

TLDR
The findings could be helpful in streamlining health care resources and interventions, developing national health care coverage policies, and possibly considering radically new insurance strategies for cancer survivors.

References

SHOWING 1-10 OF 20 REFERENCES

Estimating Health Care Costs Related to Cancer Treatment From SEER-Medicare Data

TLDR
The cost-related data available in the SEER-Medicare database is described, and techniques and methods that have been used to derive various cost estimates from these data are discussed.

Smoking-attributable medical care costs in the USA.

The Medical Expenditure Panel Survey: a national health information resource.

  • J. CohenA. Monheit R. Arnett
  • Medicine, Political Science
    Inquiry : a journal of medical care organization, provision and financing
  • 1996
TLDR
Each of the MEPS components is discussed, focusing on design enhancements that have been made since the survey was last conducted nearly a decade ago, to examine how individual and family characteristics, including the characteristics of their health insurance, affect medical care use and spending.

The relation between funding by the National Institutes of Health and the burden of disease.

TLDR
A cross-sectional study comparing estimates of disease-specific funding in 1996 with data on six measures of the burden of disease found that the acquired immunodeficiency syndrome, breast cancer, diabetes mellitus, and dementia all received relatively generous funding, regardless of which measure was used as the basis for calculating support.

Health insurance and spending among cancer patients.

TLDR
Evidence is presented to show that spending differences are due in part or completely to differences in use, which suggests that raising coverage rates will improve cancer treatment.

The burden of illness of cancer: economic cost and quality of life.

TLDR
This chapter analyzes the main measures of burden of disease as relate to cancer, including incidence and mortality, years of life lost from cancer, and cancer prevalence, and examines the impact of cancer on health- related quality of life as measured in global terms and using evaluation-oriented applications of health-related quality ofLife scales.

Some Relationships and Possible Models for State Estimates from the Medical Expenditure Panel Survey, Household Component

In recent work at the Agency for Healthcare Research and Quality, efforts have focused on production of direct estimates of expenditure variables with data from the Medical Expenditure Panel Survey,

Beneath the Averages: An Analysis of Medicare and Private Expenditures

TLDR
Despite claims by many observers that Medicare's growth is out of control, when compared to the growth in private insurance spending, Medicare does better on a per capita basis, despite the fact that Medicare experiences some disadvantages.

Reconciling Medical Expenditure Estimates from the MEPS and the NHA, 1996

TLDR
This article compares 1996 estimates of national medical care expenditures from the Medical Expenditure Panel Survey (MEPS) and the National Health Accounts (NHA), finding a much smaller difference between MEPS and a comparably-defined NHA.

The Economic Burden of Cancer

TLDR
Because of morbidity and premature mortality, large amounts of production, voluntary work in organizations, household activities, and leisure time are forgone by the patients and their families and friends.